SG11201502014XA - Hydropyrrolopyrrole derivatives for use as fatty acid synthase inhibitors - Google Patents
Hydropyrrolopyrrole derivatives for use as fatty acid synthase inhibitorsInfo
- Publication number
- SG11201502014XA SG11201502014XA SG11201502014XA SG11201502014XA SG11201502014XA SG 11201502014X A SG11201502014X A SG 11201502014XA SG 11201502014X A SG11201502014X A SG 11201502014XA SG 11201502014X A SG11201502014X A SG 11201502014XA SG 11201502014X A SG11201502014X A SG 11201502014XA
- Authority
- SG
- Singapore
- Prior art keywords
- hydropyrrolopyrrole
- derivatives
- fatty acid
- acid synthase
- synthase inhibitors
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/407—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with other heterocyclic ring systems, e.g. ketorolac, physostigmine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/472—Non-condensed isoquinolines, e.g. papaverine
- A61K31/4725—Non-condensed isoquinolines, e.g. papaverine containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pain & Pain Management (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Oncology (AREA)
- Rheumatology (AREA)
- Hematology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP12006668 | 2012-09-24 | ||
| PCT/EP2013/002606 WO2014044356A1 (en) | 2012-09-24 | 2013-08-30 | Hydropyrrolopyrrole derivatives for use as fatty acid synthase inhibitors |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11201502014XA true SG11201502014XA (en) | 2015-04-29 |
Family
ID=47088611
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11201502014XA SG11201502014XA (en) | 2012-09-24 | 2013-08-30 | Hydropyrrolopyrrole derivatives for use as fatty acid synthase inhibitors |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US9416133B2 (lt) |
| EP (1) | EP2897958B1 (lt) |
| JP (1) | JP6259460B2 (lt) |
| KR (1) | KR20150061644A (lt) |
| CN (1) | CN104640866B (lt) |
| AR (1) | AR092211A1 (lt) |
| AU (1) | AU2013320636A1 (lt) |
| BR (1) | BR112015005862A2 (lt) |
| CA (1) | CA2885673A1 (lt) |
| ES (1) | ES2608040T3 (lt) |
| HK (1) | HK1210470A1 (lt) |
| IL (1) | IL237839A0 (lt) |
| MX (1) | MX2015003542A (lt) |
| RU (1) | RU2015115278A (lt) |
| SG (1) | SG11201502014XA (lt) |
| WO (1) | WO2014044356A1 (lt) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104302358B (zh) | 2012-03-07 | 2017-12-05 | 癌症研究协会:皇家癌症医院 | 3‑芳基‑5‑取代的异喹啉‑1‑酮化合物和它们的治疗用途 |
| AR095079A1 (es) | 2013-03-12 | 2015-09-16 | Hoffmann La Roche | Derivados de octahidro-pirrolo[3,4-c]-pirrol y piridina-fenilo |
| DK2968316T3 (da) | 2013-03-13 | 2019-10-07 | Forma Therapeutics Inc | 2-hydroxy-1-{4-[(4-phenylphenyl)carbonyl]piperazin-1-yl}ethan-1-on-derivater og relaterede forbindelser som fedtsyresyntase (fasn)-inhibitorer til behandlingen af cancer |
| CN105722835B (zh) | 2013-09-11 | 2018-07-31 | 癌症研究协会:皇家癌症医院 | 3-芳基-5-取代的-异喹啉-1-酮化合物及它们的疗法应用 |
| MY187449A (en) | 2013-11-26 | 2021-09-22 | Hoffmann La Roche | New octahydro-cyclobuta [1,2-c;3,4-c']dipyrrol-2-yl |
| DK3122750T3 (da) | 2014-03-26 | 2019-11-04 | Hoffmann La Roche | Bicykliske forbindelser som autotaxin (ATX)- og lysofosfatidsyre (LPA)-produktionshæmmere |
| AU2016280255A1 (en) | 2015-06-18 | 2018-02-08 | Cephalon, Inc. | 1, 4-substituted piperidine derivatives |
| US10919875B2 (en) | 2015-06-18 | 2021-02-16 | 89Bio Ltd | Substituted 4-benzyl and 4-benzoyl piperidine derivatives |
| JP6886967B2 (ja) | 2015-09-04 | 2021-06-16 | エフ．ホフマン−ラ ロシュ アーゲーＦ． Ｈｏｆｆｍａｎｎ−Ｌａ Ｒｏｃｈｅ Ａｋｔｉｅｎｇｅｓｅｌｌｓｃｈａｆｔ | フェノキシメチル誘導体 |
| JP6876685B2 (ja) | 2015-09-24 | 2021-05-26 | エフ．ホフマン−ラ ロシュ アーゲーＦ． Ｈｏｆｆｍａｎｎ−Ｌａ Ｒｏｃｈｅ Ａｋｔｉｅｎｇｅｓｅｌｌｓｃｈａｆｔ | Ａｔｘ阻害剤としての二環式化合物 |
| CN107614505B (zh) * | 2015-09-24 | 2021-05-07 | 豪夫迈·罗氏有限公司 | 作为双重atx/ca抑制剂的新型二环化合物 |
| BR112018006024A2 (pt) | 2015-09-24 | 2020-05-12 | F. Hoffmann-La Roche Ag | Compostos bicíclicos como inibidores de atx |
| WO2017156350A1 (en) | 2016-03-09 | 2017-09-14 | K-Gen, Inc. | Methods of cancer treatment |
| WO2018167113A1 (en) | 2017-03-16 | 2018-09-20 | F. Hoffmann-La Roche Ag | New bicyclic compounds as atx inhibitors |
| RU2019132254A (ru) | 2017-03-16 | 2021-04-16 | Ф. Хоффманн-Ля Рош Аг | Гетероциклические соединения, пригодные в качестве дуальных ингибиторов atx/ca |
| KR102296703B1 (ko) | 2017-03-20 | 2021-09-01 | 포르마 세라퓨틱스 인크. | 피루베이트 키나제 (pkr) 활성화제로서의 피롤로피롤 조성물 |
| BR112021005188A2 (pt) | 2018-09-19 | 2021-06-08 | Forma Therapeutics, Inc. | tratamento de anemia falciforme com um composto de ativação de piruvato cinase r |
| US20230055923A1 (en) | 2018-09-19 | 2023-02-23 | Forma Therapeutics, Inc. | Activating pyruvate kinase r |
| TWI767148B (zh) | 2018-10-10 | 2022-06-11 | 美商弗瑪治療公司 | 抑制脂肪酸合成酶(fasn) |
| US10793554B2 (en) | 2018-10-29 | 2020-10-06 | Forma Therapeutics, Inc. | Solid forms of 4-(2-fluoro-4-(1-methyl-1H-benzo[d]imidazol-5-yl)benzoyl)piperazin-1-yl)(1-hydroxycyclopropyl)methanone |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2007216543A1 (en) * | 2006-02-15 | 2007-08-23 | F. Hoffmann-La Roche Ag | Hetero-bycyclic antiviral compounds |
| EP2010172B1 (en) * | 2006-04-07 | 2012-08-29 | Janssen Pharmaceutica N.V. | Indoles and benzoimidazoles as modulators of the histamine h4 receptor |
| WO2008059214A1 (en) * | 2006-11-13 | 2008-05-22 | Astrazeneca Ab | Bisamlde derivatives and use thereof as fatty acid synthase inhibitors |
| KR20090127307A (ko) * | 2007-03-01 | 2009-12-10 | 얀센 파마슈티카 엔.브이. | 히스타민 ｈ３ 수용체 조절제로서의 테트라하이드로이소퀴놀린 화합물 |
| AU2008268667A1 (en) * | 2007-06-22 | 2008-12-31 | Merck & Co., Inc. | 6.5-pyrrolopiperidine tachykinin receptor antagonists |
| US8614238B2 (en) | 2009-10-19 | 2013-12-24 | Boehringer Ingelheim International Gmbh | Cyclopentanecarboxamide derivatives, medicaments containing such compounds and their use |
| WO2011056635A1 (en) * | 2009-10-27 | 2011-05-12 | Glaxosmithkline Llc | Benzimidazoles as fatty acid synthase inhibitors |
| US8633183B2 (en) * | 2010-01-26 | 2014-01-21 | Boehringer Ingelheim International Gmbh | 5-alkynyl-pyrimidines |
| EP2637660A4 (en) | 2010-11-08 | 2014-04-09 | Glaxosmithkline Ip No 2 Ltd | GRAS SYNTHASE ACID INHIBITORS |
| SI2683244T1 (sl) * | 2011-03-08 | 2017-05-31 | 3-V Biosciences, Inc. | Heterociklični modulatorji sinteze lipidov |
| WO2013028445A1 (en) | 2011-08-19 | 2013-02-28 | Glaxosmithkline Llc | Fatty acid synthase inhibitors |
-
2013
- 2013-08-23 AR ARP130102988A patent/AR092211A1/es unknown
- 2013-08-30 ES ES13758748.1T patent/ES2608040T3/es active Active
- 2013-08-30 EP EP13758748.1A patent/EP2897958B1/en not_active Not-in-force
- 2013-08-30 JP JP2015532318A patent/JP6259460B2/ja not_active Expired - Fee Related
- 2013-08-30 CN CN201380049347.9A patent/CN104640866B/zh not_active Expired - Fee Related
- 2013-08-30 MX MX2015003542A patent/MX2015003542A/es unknown
- 2013-08-30 WO PCT/EP2013/002606 patent/WO2014044356A1/en active Application Filing
- 2013-08-30 RU RU2015115278A patent/RU2015115278A/ru unknown
- 2013-08-30 CA CA 2885673 patent/CA2885673A1/en not_active Abandoned
- 2013-08-30 SG SG11201502014XA patent/SG11201502014XA/en unknown
- 2013-08-30 BR BR112015005862A patent/BR112015005862A2/pt not_active IP Right Cessation
- 2013-08-30 AU AU2013320636A patent/AU2013320636A1/en not_active Abandoned
- 2013-08-30 US US14/430,630 patent/US9416133B2/en not_active Expired - Fee Related
- 2013-08-30 KR KR1020157010529A patent/KR20150061644A/ko not_active Application Discontinuation
-
2015
- 2015-03-19 IL IL237839A patent/IL237839A0/en unknown
- 2015-11-16 HK HK15111265.8A patent/HK1210470A1/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AU2013320636A1 (en) | 2015-05-07 |
| US20150252046A1 (en) | 2015-09-10 |
| EP2897958B1 (en) | 2016-09-21 |
| CN104640866B (zh) | 2017-06-06 |
| KR20150061644A (ko) | 2015-06-04 |
| AR092211A1 (es) | 2015-04-08 |
| RU2015115278A (ru) | 2016-11-20 |
| MX2015003542A (es) | 2015-07-17 |
| CA2885673A1 (en) | 2014-03-27 |
| US9416133B2 (en) | 2016-08-16 |
| JP2015529229A (ja) | 2015-10-05 |
| BR112015005862A2 (pt) | 2017-07-04 |
| JP6259460B2 (ja) | 2018-01-10 |
| CN104640866A (zh) | 2015-05-20 |
| IL237839A0 (en) | 2015-05-31 |
| ES2608040T3 (es) | 2017-04-05 |
| WO2014044356A1 (en) | 2014-03-27 |
| HK1210470A1 (en) | 2016-04-22 |
| EP2897958A1 (en) | 2015-07-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HK1210470A1 (en) | Hydropyrrolopyrrole derivatives for use as fatty acid synthase inhibitors | |
| IL261282A (en) | Furinone compounds as kinase inhibitors | |
| HK1195552A1 (en) | Pyrrolotriazinone derivatives as pi3k inhibitors pi3k | |
| HK1211027A1 (en) | Pyrrolotriazinone derivatives as pi3k inhibitors pi3k | |
| EP2757884A4 (en) | PYRAZOLOPYRIDYL COMPOUNDS AS AN ALDOSTERONE SYNTHESIS HEMMER | |
| SG11201501173SA (en) | PI3Kδ INHIBITOR | |
| IL228103A0 (en) | Amino-quinolines as kinase inhibitors | |
| EP2637660A4 (en) | GRAS SYNTHASE ACID INHIBITORS | |
| HK1210771A1 (en) | Azaindole derivatives which act as pi3k inhibitors | |
| ZA201309150B (en) | Derivatives of 1-phenyl-2-pyridinyl- alkyl alcohols as phosphodiesterase inhibitors | |
| IL228949A0 (en) | History of pyrazolospiroctone for use as acetyl-CoA carboxylase inhibitors | |
| ME02576B (me) | Derivati tetrahidropirolotiazina kao inhibitori bace | |
| EP2538787A4 (en) | TRIAZOLONE AS FATTY ACID SYNTHESIS HEMMER | |
| EP2685992A4 (en) | AMINO-QUINOLINES AS KINASE INHIBITORS | |
| EP2744333A4 (en) | FETTSÄURESYNTHASEHEMMER | |
| ZA201409497B (en) | Tetrahydroquinazolinone derivatives as parp inhibitors | |
| EP2757882A4 (en) | IMIDAZOPYRIDYL COMPOUNDS AS AN ALDOSTERONE SYNTHESIS HEMMER | |
| HK1212331A1 (en) | 4-carboxamido-isoindolinone derivatives as selective parp-1 inhibitors parp-1 4-- | |
| EP2847186A4 (en) | SUBSTITUTED AMINOCHINAZOLINES USE AS CHINESE HEMMER | |
| HK1213551A1 (zh) | 作為磷酸二酯酶抑制劑的 -苯基- -吡啶基烷基醇衍生物 | |
| EP2744788A4 (en) | Benzopiperazine derivatives as CETP inhibitors | |
| EP2857010A4 (en) | Dihydroorotic-DEHYDROGENASEHEMMER | |
| EP2782902A4 (en) | DERIVATIVES FROM PHENOXYISOBUTTERIC ACID | |
| EP2879681A4 (en) | INDOINDUBSTITUTED PYRROLOPYRIMIDINYL HIBITORS OF UBA6 |